Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression

被引:28
作者
Mondello, Patrizia [1 ,3 ]
Cuzzocrea, Salvatore [2 ]
Navarra, Michele [2 ,4 ]
Mian, Michael [5 ]
机构
[1] Univ Messina, Dept Human Pathol, Messina, Italy
[2] Univ Messina, Dept Chem, Biol, Pharmaceut & Environm Sci, Messina, Italy
[3] Mem Sloan Kettering Canc Ctr, Lymphoma Serv, New York, NY USA
[4] Hosp Bolzano, Dept Hematol & Ctr Bone Marrow Transplantat, Bolzano, Italy
[5] Med Univ Innsbruck, Dept Internal Med, Hematol Oncol, Innsbruck, Austria
关键词
multiple myeloma; micro-environment; therapeutic opportunities; osteoclast activation; angiogenesis; ENDOTHELIAL GROWTH-FACTOR; SOLUBLE INTERLEUKIN-6 RECEPTOR; FACTOR-KAPPA-B; MATRIX-METALLOPROTEINASE INHIBITOR; MESENCHYMAL STROMAL CELLS; PREDICTS POOR-PROGNOSIS; SKELETAL-RELATED EVENTS; MULTIPLE-MYELOMA; HUMAN CD38; ZOLEDRONIC ACID;
D O I
10.18632/oncotarget.14610
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite the advent of many therapeutic agents, such as bortezomib and lenalidomide that have significantly improved the overall survival, multiple myeloma remains an incurable disease. Failure to cure is multifactorial and can be attributed to the underlying genetic heterogeneity of the cancer and to the surrounding micro-environment. Understanding the mutual interaction between myeloma cells and micro-environment may lead to the development of novel treatment strategies able to eradicate this disease. In this review we discuss the principal molecules involved in the micro-environment network in multiple myeloma and the currently available therapies targeting them.
引用
收藏
页码:20394 / 20409
页数:16
相关论文
共 177 条
  • [21] Initial genome sequencing and analysis of multiple myeloma
    Chapman, Michael A.
    Lawrence, Michael S.
    Keats, Jonathan J.
    Cibulskis, Kristian
    Sougnez, Carrie
    Schinzel, Anna C.
    Harview, Christina L.
    Brunet, Jean-Philippe
    Ahmann, Gregory J.
    Adli, Mazhar
    Anderson, Kenneth C.
    Ardlie, Kristin G.
    Auclair, Daniel
    Baker, Angela
    Bergsagel, P. Leif
    Bernstein, Bradley E.
    Drier, Yotam
    Fonseca, Rafael
    Gabriel, Stacey B.
    Hofmeister, Craig C.
    Jagannath, Sundar
    Jakubowiak, Andrzej J.
    Krishnan, Amrita
    Levy, Joan
    Liefeld, Ted
    Lonial, Sagar
    Mahan, Scott
    Mfuko, Bunmi
    Monti, Stefano
    Perkins, Louise M.
    Onofrio, Robb
    Pugh, Trevor J.
    Rajkumar, S. Vincent
    Ramos, Alex H.
    Siegel, David S.
    Sivachenko, Andrey
    Stewart, A. Keith
    Trudel, Suzanne
    Vij, Ravi
    Voet, Douglas
    Winckler, Wendy
    Zimmerman, Todd
    Carpten, John
    Trent, Jeff
    Hahn, William C.
    Garraway, Levi A.
    Meyerson, Matthew
    Lander, Eric S.
    Getz, Gad
    Golub, Todd R.
    [J]. NATURE, 2011, 471 (7339) : 467 - 472
  • [22] Characiejus D, 2008, ANTICANCER RES, V28, P1139
  • [23] THE HUMAN HEMATOPOIETIC COLONY-STIMULATING FACTORS
    CLARK, SC
    KAMEN, R
    [J]. SCIENCE, 1987, 236 (4806) : 1229 - 1237
  • [24] Notch signaling drives multiple myeloma induced osteoclastogenesis
    Colombo, Michela
    Thuemmler, Katja
    Mirandola, Leonardo
    Garavelli, Silvia
    Todoerti, Katia
    Apicella, Luana
    Lazzari, Elisa
    Lancellotti, Marialuigia
    Platonova, Natalia
    Akbar, Moeed
    Chiriva-Internati, Maurizio
    Soutar, Richard
    Neri, Antonino
    Goodyear, Carl S.
    Chiaramonte, Raffaella
    [J]. ONCOTARGET, 2014, 5 (21) : 10393 - 10406
  • [25] AMINO-ACID AND CDNA SEQUENCES OF A VASCULAR ENDOTHELIAL-CELL MITOGEN THAT IS HOMOLOGOUS TO PLATELET-DERIVED GROWTH-FACTOR
    CONN, G
    BAYNE, ML
    SODERMAN, DD
    KWOK, PW
    SULLIVAN, KA
    PALISI, TM
    HOPE, DA
    THOMAS, KA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (07) : 2628 - 2632
  • [26] INHIBITION OF CARTILAGE AND BONE DESTRUCTION IN ADJUVANT ARTHRITIS IN THE RAT BY A MATRIX METALLOPROTEINASE INHIBITOR
    CONWAY, JG
    WAKEFIELD, JA
    BROWN, RH
    MARRON, BE
    SEKUT, L
    STIMPSON, SA
    MCELROY, A
    MENIUS, JA
    JEFFREYS, JJ
    CLARK, RL
    MCGEEHAN, GM
    CONNOLLY, KM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (02) : 449 - 457
  • [27] Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
    Croucher, PI
    Shipman, CM
    Lippitt, J
    Perry, M
    Asosingh, K
    Hijzen, A
    Brabbs, AC
    van Beek, EJR
    Holen, I
    Skerry, TM
    Dunstan, CR
    Russell, GR
    Van Camp, B
    Vanderkerken, K
    [J]. BLOOD, 2001, 98 (13) : 3534 - 3540
  • [28] Dales JP, 2003, ANN PATHOL, V23, P297
  • [29] COLLAGENASE EXPRESSION IN THE LUNGS OF TRANSGENIC MICE CAUSES PULMONARY-EMPHYSEMA
    DARMIENTO, J
    DALAL, SS
    OKADA, Y
    BERG, RA
    CHADA, K
    [J]. CELL, 1992, 71 (06) : 955 - 961
  • [30] The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade
    DavisSmyth, T
    Chen, H
    Park, J
    Presta, LG
    Ferrara, N
    [J]. EMBO JOURNAL, 1996, 15 (18) : 4919 - 4927